Login to Your Account

FDA Clears Amgen's Vectibix, Adds To ImClone's Troubles

By Aaron Lorenzo

Friday, September 29, 2006
Late Wednesday, the FDA approved the next in a growing line of targeted cancer therapies, Amgen Inc.'s Vectibix (panitumumab). (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription